Prediction of severe adverse events, modes of action and drug treatments for COVID-19’s complications

Following SARS-CoV-2 infection, some COVID-19 patients experience severe host driven adverse events. To treat these complications, their underlying etiology and drug treatments must be identified. Thus, a novel AI methodology MOATAI-VIR, which predicts disease-protein-pathway relationships and repur...

Descripción completa

Detalles Bibliográficos
Autores principales: Astore, Courtney, Zhou, Hongyi, Jacob, Joshy, Skolnick, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531388/
https://www.ncbi.nlm.nih.gov/pubmed/34675303
http://dx.doi.org/10.1038/s41598-021-00368-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531388/
https://www.ncbi.nlm.nih.gov/pubmed/34675303
http://dx.doi.org/10.1038/s41598-021-00368-6

Ejemplares similares